Trial intelligence / Profile preview

Enantone in Central Precocious Puberty (China, Phase IV)

CTR20140148Phase 4Completed

Sponsor
Takeda
Start
May 2015
Modality
Small Molecules, Peptides
Countries
1
01

Overview

A Phase 4 trial of leuprolide in central precocious puberty (CPP), sponsored by Takeda. Started May 2015; status: completed.

02

Drugs

leuprolide
03

Conditions

central precocious puberty (CPP)

Beyond the preview

Go deeper on CTR20140148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call